Vanguard (RMD) reports 11.96M-share stake — 8.21% disclosed

Rhea-AI Filing Summary

ResMed Inc beneficial ownership reported by Vanguard Capital Management: 11,961,706.2 shares representing 8.21% of common stock as of 03/31/2026. The filing states these holdings reflect securities held across Vanguard funds and affiliates, with dispositive power exercised by Vanguard Capital Management LLC.

Insights

Institutional Ownership Analyst

Large passive stake disclosed by a major asset manager.

Vanguard Capital Management reports 11,961,706.2 shares ( 8.21%) of ResMed common stock as of 03/31/2026. The filing attributes voting and dispositive arrangements to Vanguard and named affiliates and notes holdings include depository receipts and fund sleeves.

Because the filing is a Schedule 13G, it indicates investment management/ownership reporting rather than an active change in control. Subsequent filings or amendments would show any change in intent or percent ownership.

Key Figures

Beneficially owned shares: 11,961,706.2 shares Percent of class: 8.21% Sole voting power: 2,495,290.20 shares +1 more

4 metrics

Beneficially owned shares 11,961,706.2 shares Beneficial ownership reported as of <date>03/31/2026</date>

Percent of class 8.21% Percent of ResMed common stock (as reported)

Sole voting power 2,495,290.20 shares Shares with sole power to vote (reported)

Sole dispositive power 11,961,706.20 shares Shares with sole power to dispose (reported)

Key Terms

Schedule 13G, beneficially owned, sole dispositive power, depository receipts

4 terms

Schedule 13G regulatory

"ResMed Inc Common Stock 761152107 03/31/2026 schemaVersion"

A Schedule 13G is a formal document that investors file with the government when they acquire a large ownership stake in a company, usually for investment purposes rather than control. It helps keep the public informed about who owns significant parts of a company's shares, which can influence how the company is managed and how investors make decisions. Filing this schedule is important for transparency and understanding the ownership landscape of publicly traded companies.

beneficially owned financial

"Amount beneficially owned: 11961706.2"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 11961706.20"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

depository receipts market

"The holdings reported herein include securities in the form of depository receipts"

A depository receipt is a tradable certificate issued by a bank that represents ownership of shares held in a foreign company, letting investors buy and sell those shares on their local stock market without dealing with the foreign exchange and custody details. Think of it as a local receipt for a piece of a foreign company kept in a secure vault abroad; it matters because it makes international investing easier, often increases liquidity, and can affect dividend payments and currency risk.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

ResMed Inc

(Name of Issuer)

Common Stock

(Title of Class of Securities)

761152107

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 761152107

1

Names of Reporting Persons

Vanguard Capital Management

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

PENNSYLVANIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,495,290.20
6	Shared Voting Power 0.00
7	Sole Dispositive Power 11,961,706.20
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

11,961,706.20

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

8.21 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: In accordance with SEC Release No. 34-39538 (January 12, 1998), this Schedule 13G reflects the securities beneficially owned, or deemed to be beneficially owned, by Vanguard Capital Management LLC and the following affiliates of Vanguard Capital Management LLC or business divisions of such affiliates: Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC and Vanguard Investments Australia Ltd. This Schedule 13G includes securities held by Vanguard funds, or sleeves thereof, over which Vanguard Capital Management LLC exercises dispositive power, in addition to securities held by clients over which the affiliates or business divisions of such affiliates indicated above exercise dispositive and/or voting power. This Schedule 13G does not include securities, if any, beneficially owned by other subsidiaries or affiliates of Vanguard Capital Management LLC, or business divisions of such subsidiaries, whose ownership of securities is disaggregated from that of the reporting business unit in accordance with such release. The holdings reported herein include securities in the form of depository receiptsThe CUSIP Number listed throughout this filing is the CUSIP assigned to the Ordinary Shares of the Issuer.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: ResMed Inc
(b)	Address of issuer's principal executive offices: 9001 Spectrum Center Blvd, San Diego, CA, 92123
Item 2.
(a)	Name of person filing: Vanguard Capital Management
(b)	Address or principal business office or, if none, residence: 100 Vanguard Blvd,, Malvern, PA, 19355
(c)	Citizenship: PA
(d)	Title of class of securities: Common Stock
(e)	CUSIP Number(s): 761152107
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 11961706.2
(b)	Percent of class: 8.21 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2495290.20
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 11961706.20
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Vanguard Capital Management, including investment companies registered under the Investment Company Act of 1940 and other managed accounts, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the securities reported herein.No one other person's interest in the securities reported herein is more than 5%.
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Vanguard Capital Management

Signature:	Ashley Grim
Name/Title:	Head of Global Fund Administration
Date:	04/29/2026

FAQ

What stake does Vanguard Capital Management report in ResMed (RMD)?

Vanguard reports beneficial ownership of 11,961,706.2 shares, representing 8.21% of ResMed common stock as of 03/31/2026. The amount includes holdings across funds and affiliates over which Vanguard exercises dispositive power.

Does Vanguard have voting authority over the ResMed shares?

Yes. The filing shows Vanguard has sole voting power for 2,495,290.20 shares and sole dispositive power for 11,961,706.20 shares, reflecting control over voting and disposition for identified holdings.

Is this Schedule 13G filing an indication Vanguard seeks control of ResMed?

No. A Schedule 13G is typically used for passive or investment-management holdings. The filing lists beneficial ownership and affiliate arrangements but does not state an intent to influence or control the company.

Who else is listed as exercising authority alongside Vanguard?

The filing names Vanguard affiliates and business divisions, including Vanguard Asset Management Limited, Vanguard Fiduciary Trust Company, Vanguard Global Advisers, LLC, and Vanguard Investments Australia Ltd, which hold or advise on portions of the reported securities.

Are the reported holdings held directly or via funds?

The filing states holdings include securities held by Vanguard funds or fund sleeves and by client accounts over which the named affiliates exercise dispositive power; specific fund-by-fund breakdowns are not provided in the excerpt.